Lv21
130 积分 2022-12-02 加入
High-concentration biologic formulations: challenges, strategies, and emerging technologies for subcutaneous delivery
4小时前
已完结
mRNA-encoding CD19-targeting T cell engager for refractory immune thrombocytopenia
10天前
已完结
Biophysical properties of the clinical-stage antibody landscape
1个月前
已完结
GPNMB: a potent inducer of immunosuppression in cancer
1个月前
已完结
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors
1个月前
已完结
Engineering of acidic pH-responsive anti-CD3 binding antibodies
5个月前
已完结
A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity
7个月前
已完结
B7-H3-mediated cis-inhibition of EGFR by a tumor-selective bispecific antibody enhances anti-tumor efficacy and minimizes toxicities
7个月前
已完结
De Novo Design of Peptide Masks Enables Rapid Generation of Conditionally-Active Miniprotein Binders
7个月前
已完结
Characterization of an anti-STEAP1 T-Cell Dependent Bispecific Antibody for the Treatment of Prostate Cancer and Associated Toxicity in Cynomolgus Monkeys
8个月前
已完结
皖公网安备34019202002308
